Ascletis Pharma Inc
HKEX:1672

Watchlist Manager
Ascletis Pharma Inc Logo
Ascletis Pharma Inc
HKEX:1672
Watchlist
Price: 1.77 HKD -3.8% Market Closed
Market Cap: 1.7B HKD
Have any thoughts about
Ascletis Pharma Inc?
Write Note

Wall Street
Price Targets

Price Targets Summary
Ascletis Pharma Inc

Wall Street analysts forecast Ascletis Pharma Inc stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for Ascletis Pharma Inc is 2.03 HKD with a low forecast of 2.01 HKD and a high forecast of 2.09 HKD.

Lowest
Price Target
2.01 HKD
14% Upside
Average
Price Target
2.03 HKD
15% Upside
Highest
Price Target
2.09 HKD
18% Upside
Ascletis Pharma Inc Competitors:
Price Targets
2256
Abbisko Cayman Ltd
171% Upside
MRUS
Merus NV
91% Upside
7774
Japan Tissue Engineering Co Ltd
147% Upside
AELIS
Aelis Farma SA
229% Upside
ZYME
Zymeworks Inc
23% Upside
GILD
Gilead Sciences Inc
8% Upside
LCTX
Lineage Cell Therapeutics Inc
684% Upside
ANIK
Anika Therapeutics Inc
55% Upside

Revenue
Forecast

Revenue Estimate
Ascletis Pharma Inc

For the last 6 years the compound annual growth rate for Ascletis Pharma Inc's revenue is 1%. The projected CAGR for the next 3 years is 12%.

1%
Past Growth
12%
Estimated Growth
Estimates Accuracy
-25%
Average Miss

Operating Income
Forecast

Operating Income Estimate
Ascletis Pharma Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
22%
Average Beat

Net Income
Forecast

Net Income Estimate
Ascletis Pharma Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
94%
Average Beat

See Also

Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is Ascletis Pharma Inc's stock price target?
Price Target
2.03 HKD

According to Wall Street analysts, the average 1-year price target for Ascletis Pharma Inc is 2.03 HKD with a low forecast of 2.01 HKD and a high forecast of 2.09 HKD.

What is Ascletis Pharma Inc's Revenue forecast?
Projected CAGR
12%

For the last 6 years the compound annual growth rate for Ascletis Pharma Inc's revenue is 1%. The projected CAGR for the next 3 years is 12%.

Back to Top